In one of the biggest breakthroughs in schizophrenia research in recent times, Professor Cynthia Shannon Weickert at Neuroscience Research Australia (NeuRA) has identified immune cells in greater amounts in the brains of some people with schizophrenia. The study published today in Molecular Psychiatry has the potential to transform global schizophrenia research and open new avenues for developing targeted immune cell therapies.
One in every 100 Australians lives with schizophrenia. No single cause of schizophrenia has been identified, and this has prevented the development of a cure. The current treatments for schizophrenia are designed to suppress symptoms rather than target underlying causes of the disorder. These drugs only partially relieve symptoms and can produce unwanted side effects.
To recognise the significance of this discovery Professor Shannon Weickert says you first need to understand most scientists have had a long held belief that immune cells were independent from the brain pathology in psychotic illnesses.
“In our study, we challenged this assumption that immune cells were independent of the brain in psychiatric illness and made an exciting discovery. We identified immune cells as a new player in the brain pathology of schizophrenia,” said Professor Shannon Weickert.
Current schizophrenia research has focused on the status of three brain cells: the neurons; the glial cells, which support the neurons; and the endothelial cells, which coat the blood vessels. Employing new molecular techniques allowed Professor Shannon Weickert and her team to identify the presence of a fourth cell, the macrophage, a type of immune cell in the brain tissue of people with schizophrenia who show high levels of inflammation.
Professor Shannon Weickert said immune cells have previously been ignored as they had long been viewed simply as travelers just thought to be passing by, undertaking surveillance work. They have never been a suspect until now.
“To find immune cells along the blood brain barrier in increased amounts in people with schizophrenia is an exciting discovery. It suggests immune cells themselves may be producing these inflammatory signals in the brains of people living with schizophrenia,” said Professor Shannon Weickert.
“We have observed in people with schizophrenia, the glial cells, one of the local residents, become inflamed and produce distress signals which change the status of the endothelial cells.
“We think this may cause the endothelial cells to extend sticky tentacles, so when the immune cells travel by some are captured. These cells may transmigrate across the blood brain barrier entering the brain in greater amounts in some people with schizophrenia compared to people without the disorder.”
This discovery shows that specific immune cells are in the brains of some people with schizophrenia in close enough proximity to the neurons to do damage.
Professor Peter Schofield, CEO of NeuRA said this innovative new research has the ability to alter the way in which we may be able to diagnose and treat schizophrenia.
“This breakthrough demonstrates the value of the NSW Government’s support for Professor Shannon Weickert as NSW Chair of Schizophrenia Research, which has delivered new insights that the community seeks,” said Professor Schofield.
Professor Shannon Weickert is encouraging a cross-collaborative approach between neuroscientists and immunologists globally, to work together to develop treatments targeting this abnormal immune pathology of schizophrenia.
“This opens whole new avenues for therapy, because it suggests that the pathology of schizophrenia could be within the immune cells and the immune cells could be contributing to the symptoms of schizophrenia,” said Professor Shannon Weickert.
Professor Shannon Weickert is uniquely motivated in her work, with her twin-brother being diagnosed with schizophrenia when he was 17 years old.
Learn more: Schizophrenia breakthrough
The Latest on: Schizophrenia
via Google News
The Latest on: Schizophrenia
- Fatal arson attacker showed signs of schizophrenia on April 17, 2019 at 11:08 am
The suspect in an early morning arson and killing spree Wednesday exhibited signs of schizophrenia, claiming his fatal attack was in self-defense against "forces that threatened me," police said at a ... […]
- MD Magazine® Launches Schizophrenia Treatment Approaches and Relapse Prevention Video Series on April 17, 2019 at 10:43 am
CRANBURY, N.J.--(BUSINESS WIRE)--MD Magazine®, a digital portal focused on providing physicians with the most valuable and up-to-date specialty- and disease-specific resources to help them provide the ... […]
- Marijuana For Treating Schizophrenia And Tourette Syndrome on April 17, 2019 at 10:14 am
Regardless of the history of marijuana in folk pharmacopoeias, its clinical studies on medicinal effects are still limited in most areas. However, there are preliminary results of research on this ... […]
- Political Schizophrenia on April 17, 2019 at 3:35 am
In the 1950s, my father was a young boy growing up in rural Tennessee near Memphis. He picked cotton and strawberries, slaughtered hogs, hunted rabbit, and swam in the mud creeks filled with water ... […]
- Benny and Joon and a Good Look at Schizophrenia on April 16, 2019 at 1:40 pm
Bruce Chadwick lectures on history and film at Rutgers University in New Jersey. He also teaches writing at New Jersey City University. He holds his PhD from Rutgers and was a former editor for ... […]
- Early Stresses Contribute to Schizophrenia on April 16, 2019 at 5:20 am
Patients with schizophrenia were found to be vulnerable to environmental factors that are expressed as schizophrenia, including environmental stress in utero, possibly due to inadequate stress ... […]
- ALKS 3831 mitigates weight gain in phase 3 schizophrenia study on April 16, 2019 at 4:13 am
Patients with schizophrenia treated with ALKS 3831, a combination of olanzapine and samidorphan, had less weight gain than those treated with olanzapine alone, according to a presentation from the ... […]
- How to Treat Schizophrenia, According to a Psychiatrist on April 15, 2019 at 9:25 am
Schizophrenia is a complex, lifelong disorder that needs specialized, long-term treatment—and it’s a disorder that tends to be even harder to treat than other mental illnesses. “We aren’t sure why, ... […]
- More Evidence Schizophrenia Combo Therapy Blunts Weight Gain on April 15, 2019 at 8:50 am
"Olanzapine is one of the most effective antipsychotics that we have, but its use has been limited by the weight gain and waist circumference increases that are associated with it. This new ... […]
via Bing News